“EFFICACY OF NEWER GLP-1 RECEPTOR AGONISTS ON NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES”. The Research of Medical Science Review, vol. 3, no. 5, May 2025, pp. 290-4, http://thermsr.com/index.php/Journal/article/view/1109.